• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Infect Dis . Use of Influenza Antivirals to Prevent Transmission

tetano

Editor, Senior Moderator
J Infect Dis


. 2025 Oct 17;232(Supplement_3):S215-S226.
doi: 10.1093/infdis/jiaf116. Use of Influenza Antivirals to Prevent Transmission

Benjamin J Cowling[SUP] 1 2 [/SUP], Yun Lin[SUP] 1 [/SUP], Hideyuki Ikematsu[SUP] 3 [/SUP]



Affiliations
Abstract

Influenza antivirals play an important role in the prevention and control of influenza. We reviewed data on the effectiveness of influenza antivirals for reducing influenza transmission. We found that antiviral prophylaxis, whether given pre- or postexposure, has been shown to reduce the risk of symptomatic influenza in a variety of settings and populations. During pandemic responses, antiviral prophylaxis could play an important role, as demonstrated by the use of amantadine in the 1968-1969 influenza A(H3N2) pandemic and oseltamivir during the 2009-2010 influenza A(H1N1)pdm09 pandemic. Antiviral treatment reduces symptom severity, prevents complications, and can reduce onward transmission of infection. However, resistance, accessibility, and timing pose challenges. Future research directions include innovative therapies and combination treatments. Continued research and stewardship are crucial to optimize antiviral impact.


 
Back
Top